117 related articles for article (PubMed ID: 11561119)
1. High circulating levels of soluble scavenger receptors (sCD5 and sCD6) in patients with primary Sjögren's syndrome.
Ramos-Casals M; Font J; García-Carrasco M; Calvo J; Places L; Padilla O; Cervera R; Bowen MA; Lozano F; Ingelmo M
Rheumatology (Oxford); 2001 Sep; 40(9):1056-9. PubMed ID: 11561119
[TBL] [Abstract][Full Text] [Related]
2. Pattern of soluble CD5 and CD6 lymphocyte receptors in critically ill patients with septic syndromes.
Aibar J; Martínez-Florensa M; Castro P; Carrasco E; Escoda-Ferran C; Fernández S; Butjosa M; Hernández C; Rinaudo M; Lozano F; Nicolás JM
J Crit Care; 2015 Oct; 30(5):914-9. PubMed ID: 26031813
[TBL] [Abstract][Full Text] [Related]
3. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome.
Ramos-Casals M; Brito-Zerón P; Yagüe J; Akasbi M; Bautista R; Ruano M; Claver G; Gil V; Font J
Rheumatology (Oxford); 2005 Jan; 44(1):89-94. PubMed ID: 15381790
[TBL] [Abstract][Full Text] [Related]
4. Circulating concentrations of soluble L-selectin (CD62L) in patients with primary Sjögren's syndrome.
García-Carrasco M; Pizcueta P; Cervera R; Ramos-Casals M; Sisó A; de La Red G; Ingelmo M; Font J; Engel P
Ann Rheum Dis; 2000 Apr; 59(4):297-9. PubMed ID: 10733478
[TBL] [Abstract][Full Text] [Related]
5. Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features.
Garcíc-Carrasco M; Font J; Filella X; Cervera R; Ramos-Casals M; Sisó A; Aymamí A; Ballesta AM; Ingelmo M
Clin Exp Rheumatol; 2001; 19(4):411-5. PubMed ID: 11491496
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of soluble CD44 in primary Sjögren's syndrome.
Levesque MC; Mackin DA; Fleming JA; St Clair EW
J Rheumatol; 2000 Jun; 27(6):1444-9. PubMed ID: 10852268
[TBL] [Abstract][Full Text] [Related]
7. BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands.
Quartuccio L; Salvin S; Fabris M; Maset M; Pontarini E; Isola M; De Vita S
Rheumatology (Oxford); 2013 Feb; 52(2):276-81. PubMed ID: 22879463
[TBL] [Abstract][Full Text] [Related]
8. Cell-free CD5 in patients with rheumatic diseases.
Jamin C; Magadur G; Lamour A; Mackenzie L; Lydyard P; Katsikis P; Youinou P
Immunol Lett; 1992 Jan; 31(1):79-83. PubMed ID: 1372282
[TBL] [Abstract][Full Text] [Related]
9. Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome.
Agmon-Levin N; Kivity S; Tzioufas AG; López Hoyos M; Rozman B; Efes I; Shapira Y; Shamis A; Amital H; Youinou P; Shoenfeld Y
J Autoimmun; 2012 Sep; 39(3):234-9. PubMed ID: 22835660
[TBL] [Abstract][Full Text] [Related]
10. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome.
Fragoulis GE; Vakrakou AG; Papadopoulou A; Germenis A; Kanavakis E; Moutsopoulos HM; Manoussakis MN
J Autoimmun; 2015 Jan; 56():12-22. PubMed ID: 25228497
[TBL] [Abstract][Full Text] [Related]
11. Activation antigens expressed on T-cells of the peripheral blood in Sjögren's syndrome and rheumatoid arthritis.
Ichikawa Y; Shimizu H; Yoshida M; Arimori S
Clin Exp Rheumatol; 1990; 8(3):243-9. PubMed ID: 1974181
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to CD4 in primary Sjögren's syndrome.
Henriksson G; Manthorpe R; Bredberg A
Rheumatology (Oxford); 2000 Feb; 39(2):142-7. PubMed ID: 10725063
[TBL] [Abstract][Full Text] [Related]
13. Complement C3b receptors on erythrocytes, circulating immune complexes, and complement C3 split products in patients with primary Sjögren's syndrome.
Thomsen BS; Oxholm P; Manthorpe R; Nielsen H
Arthritis Rheum; 1986 Jul; 29(7):857-62. PubMed ID: 2943291
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of apoptosis-related antigens, Fas and bcl-2, on circulating T-lymphocyte subsets in primary Sjögren's syndrome.
Ichikawa Y; Arimori K; Yoshida M; Horiki T; Hoshina Y; Morita K; Uchiyama M; Shimizu H; Moriuchi J; Takaya M
Clin Exp Rheumatol; 1995; 13(3):307-13. PubMed ID: 7554556
[TBL] [Abstract][Full Text] [Related]
15. Serum soluble adhesion molecules (sICAM-1, sVCAM-1, sE-selectin) and neopterin in patients with Sjögren's syndrome.
Andrýs C; Krejsek J; Slezák R; Drahosová M; Kopecký O
Acta Medica (Hradec Kralove); 1999; 42(3):97-101. PubMed ID: 10677896
[TBL] [Abstract][Full Text] [Related]
16. The expression and function of CD3 and CD5 in patients with primary Sjögren's syndrome.
Dauphinée MJ; Tovar Z; Ballester A; Talal N
Arthritis Rheum; 1989 Apr; 32(4):420-9. PubMed ID: 2468337
[TBL] [Abstract][Full Text] [Related]
17. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome.
Maria NI; van Helden-Meeuwsen CG; Brkic Z; Paulissen SM; Steenwijk EC; Dalm VA; van Daele PL; Martin van Hagen P; Kroese FG; van Roon JA; Harkin A; Dik WA; Drexhage HA; Lubberts E; Versnel MA
Arthritis Rheumatol; 2016 Jul; 68(7):1688-99. PubMed ID: 26866723
[TBL] [Abstract][Full Text] [Related]
18. CD5+ B lymphocytes and other lymphocyte subsets in primary Sjögren's syndrome.
van de Merwe JP; van den Beemd MW; Hooijkaas H
Neth J Med; 1992 Apr; 40(3-4):158-64. PubMed ID: 1376444
[TBL] [Abstract][Full Text] [Related]
19. The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome.
Mariette X; Roux S; Zhang J; Bengoufa D; Lavie F; Zhou T; Kimberly R
Ann Rheum Dis; 2003 Feb; 62(2):168-71. PubMed ID: 12525388
[TBL] [Abstract][Full Text] [Related]
20. [Expression of CD4+ CD25+ regulatory T cells in peripheral blood and salivary gland of patients with primary Sjögren's syndrome].
Li XM; Li XP; Qian L; Wang GS; Zhang H; Zhei ZM; Li Q; Chen K; Wang XQ; Wang YP
Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(15):1034-6. PubMed ID: 17672966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
